Jessica Karr is the founder and managing director of Coyote Ventures, an investment firm that focuses on backing founders who are solving problems that disproportionately affect overlooked populations with a foundation in women’s health. She is also a limited partner of Portfolia FemTech II Fund, designed for women who want to back entrepreneurial companies for returns and impact, among other advisory roles.
SEARCH RESULTS
2. Jessica Karr of Coyote Ventures: Innovation in Healthcare, Innovation in Building Visibility
Jessica Karr is the founder and managing director of Coyote Ventures, an investment firm that focuses on backing founders who are solving problems that disproportionately affect overlooked populations with a foundation in women’s health. She is also a limited partner of Portfolia FemTech II Fund, designed for women who want to back entrepreneurial companies for returns and impact, among other advisory roles.
Special Collaboration – The Mindshare Podcast and Fiftyfaces Productions – Women’s Health in the Spotlight – Trailer
Inspiring people advancing women’s health
This podcast series builds on our successful global Women-in-Tech healthcare series, as well as our capsule collections focused on maternal mortality and changemakers in medicine and science. With a focus on profiling inspiring healthcare professionals, investors, tech professionals, entrepreneurs, and capital providers, we examine the trends, the themes and opportunities within the healthcare segment.We drill down on the under invested area of women’s health, ask why this under-investment persists and examine innovations and community initiatives to raise awareness, build solidarity, and create impact
186. Maneesha Ghiya of FemHealth Ventures: Amplifying Women in Healthcare and Beyond
Maneesha Ghiya is Managing Partner and Founder of FemHealth Ventures, a firm focused on providing investment capital to entrepreneurs focused on women’s health. Investing in healthcare since 2000, Maneesha has invested via public equities, private equities and as a hedge fund specialist. She is a Senior Advisor to ExSight Ventures, an ophthalmology-focused venture capital fund and serves on multiple boards